Showing results (81-90 of 128) with videos related to
Sort By:
Pageof 13
Muscle & Nerve|January 4, 2020
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALSNamita A Goyal, James D Berry, Anthony Windebank, et al.Plos Medicine|October 31, 2024
Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trialSteven Perrin, Shafeeq Ladha, Nicholas Maragakis, et al.Neurodegenerative Disease Management|November 24, 2021
MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study designBjörn Oskarsson, Nicholas Maragakis, Richard S Bedlack, et al.Journal of Medical Economics|March 17, 2023
Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALSPaulos Gebrehiwet, Lisa Meng, Stacy A Rudnicki, et al.Journal of Neurology|January 28, 2024
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathologyPedram Parnianpour, Michael Benatar, Hannah Briemberg, et al.Human Brain Mapping|December 15, 2021
Distinct patterns of progressive gray and white matter degeneration in amyotrophic lateral sclerosisAbdullah Ishaque, Daniel Ta, Muhammad Khan, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 18, 2018
Understanding the use of NIV in ALS: results of an international ALS specialist surveyTerry D Heiman-Patterson, Merit E Cudkowicz, Mamede De Carvalho, et al.Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|August 13, 2023
SF2Former: Amyotrophic lateral sclerosis identification from multi-center MRI data using spatial and frequency fusion transformerRafsanjany Kushol, Collin C Luk, Avyarthana Dey, et al.Journal of Neuromuscular Diseases|April 19, 2021
A Canadian Adult Spinal Muscular Atrophy Outcome Measures Toolkit: Results of a National Consensus using a Modified Delphi MethodJeremy Slayter, Victoria Hodgkinson, Josh Lounsberry, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 7, 2022
Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approachesCorey T McMillan, Joanne Wuu, Katya Rascovsky, et al.Pageof 13